How COVID damages heart found, may lead to new treatments
- While COVID-19 and influenza are both severe respiratory viruses, they appeared to affect cardiac tissue very differently.
- The study conducted on a small group of people found that COVID-19 damaged the DNA in heart tissue.
- DNA damage and repair mechanisms are related to chronic diseases such as diabetes, cancer, atherosclerosis and neurodegenerative disorders.
Researchers have discovered how COVID-19 infection damages the heart tissue, paving the way for better treatments for the condition. The study conducted on a small group of people found that COVID-19 damaged the DNA in heart tissue, which was not detected in influenza samples.
The researchers noted that while COVID-19 and influenza are both severe respiratory viruses, they appeared to affect cardiac tissue very differently.
"In comparison to the 2009 flu pandemic,
"During our study, we couldn't detect viral particles in the cardiac tissues of COVID-19 patients, but what we found was tissue changes associated with DNA damage and repair," Kulasinghe said.
DNA damage and repair mechanisms are related to chronic diseases such as diabetes, cancer, atherosclerosis and neurodegenerative disorders, so understanding why this is happening in COVID-19 patients is important, the researchers said.
Data associated with the impact of COVID-19 on the heart has previously been limited to blood biomarkers and physiological measurement, as obtaining heart biopsy samples is invasive.
The study, recently published in the journal
The findings provided insights into how COVID-19 impacted the body compared to other respiratory viruses.
"When we looked at the influenza cardiac tissue samples, we identified that it caused excess inflammation," said Professor John Fraser, who established the international COVID-19 Critical Care Consortium.
"Whereas we found COVID-19 attacked the heart's DNA -- probably directly and not just as a knock-on from inflammation," Fraser said.
The study highlights that the two viruses appear to affect cardiac tissue very differently, which the resaerchers want to get a better understanding of in larger cohort studies.
"What we have categorically shown is that COVID is not 'just like the flu'," said Fraser.
"This study helps us understand how COVID-19 affects that heart, and that is the first step in working out what treatments might be best to repair that heart," he added.
SEE ALSO: iPad's Apple SIM can no longer be used to activate cellular plans
Here’s everything you need to know about the made-in-India lightweight combat helicopter
JioBook, a 4G-enabled budget laptop is expected to launch soon at ₹15,000
Popular on BI
- 911 dispatchers say skiers are accidentally setting off Apple's new crash-detection technology without realizing, triggering emergency calls
- The rally in stocks will trick investors into thinking the bear market is over, but there's still a case for the S&P 500 to fall another 26% next year, Morgan Stanley's Mike Wilson says
- Adani may be the richest Indian but Ambani’s RIL retains the top spot on Hurun's list of most valuable companies
- Rupee gains 18 paise to 81.08 against US dollar
- Indian markets open marginally lower amid weak global cues – PB Fintech, Maruti Suzuki, Tata Motors, M&M, Bajaj Auto and other stocks in focus
- 234-year-old company EID Parry is only a tad more valuable than year-old unicorn GlobalBees
- Here are the best apps and games on Google Play in India 2022
- Top 10 companies with the highest net profit in India as per Hurun 2022 list